2022-11-28 | NDAQ:PGNY | Press Release

Giuseppe Meazza

Shipments of Key Fertility Medication Have Resumed NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that it is raising its financial guidance for the fourth quarter and […]